PL1890682T3 - Zastosowanie mieszanin polimerów do wytwarzania powlekanych postaci leków oraz postaci leku z mieszaną powłoką polimerową - Google Patents

Zastosowanie mieszanin polimerów do wytwarzania powlekanych postaci leków oraz postaci leku z mieszaną powłoką polimerową

Info

Publication number
PL1890682T3
PL1890682T3 PL06723193T PL06723193T PL1890682T3 PL 1890682 T3 PL1890682 T3 PL 1890682T3 PL 06723193 T PL06723193 T PL 06723193T PL 06723193 T PL06723193 T PL 06723193T PL 1890682 T3 PL1890682 T3 PL 1890682T3
Authority
PL
Poland
Prior art keywords
production
polymeric coating
polymer mixtures
mixed polymeric
pharmaceutical formulation
Prior art date
Application number
PL06723193T
Other languages
English (en)
Polish (pl)
Inventor
Christian Meier
Karin Knuppen
Hans-Ulrich Petereit
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of PL1890682T3 publication Critical patent/PL1890682T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
PL06723193T 2005-05-25 2006-03-03 Zastosowanie mieszanin polimerów do wytwarzania powlekanych postaci leków oraz postaci leku z mieszaną powłoką polimerową PL1890682T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005024614A DE102005024614A1 (de) 2005-05-25 2005-05-25 Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
EP06723193.6A EP1890682B1 (de) 2005-05-25 2006-03-03 Verwendung vom polymermischungen zur herstellung von überzogenen arzneiformen sowie arzneiform mit
PCT/EP2006/001949 WO2006125483A1 (de) 2005-05-25 2006-03-03 Verwendung vom polymermischungen zur herstellung von überzogenen arzneiformen sowie arzneiform mit

Publications (1)

Publication Number Publication Date
PL1890682T3 true PL1890682T3 (pl) 2017-10-31

Family

ID=36607494

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06723193T PL1890682T3 (pl) 2005-05-25 2006-03-03 Zastosowanie mieszanin polimerów do wytwarzania powlekanych postaci leków oraz postaci leku z mieszaną powłoką polimerową

Country Status (15)

Country Link
US (1) US20080193522A1 (enExample)
EP (1) EP1890682B1 (enExample)
JP (1) JP5582701B2 (enExample)
KR (1) KR101387835B1 (enExample)
CN (1) CN101137354B (enExample)
BR (1) BRPI0610206B8 (enExample)
CA (1) CA2606587C (enExample)
DE (1) DE102005024614A1 (enExample)
ES (1) ES2628962T3 (enExample)
HU (1) HUE032869T2 (enExample)
IL (1) IL187535A0 (enExample)
MX (1) MX363064B (enExample)
PL (1) PL1890682T3 (enExample)
SI (1) SI1890682T1 (enExample)
WO (1) WO2006125483A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
WO2008070072A2 (en) * 2006-12-01 2008-06-12 Mutual Pharmaceutical Company, Inc. Carvedilol forms, compositions, and methods of preparation thereof
AU2008210327B2 (en) * 2007-01-31 2011-06-16 Methylation Sciences International Srl Extended release pharmaceutical formulations of S-adenosylmethionine
JP5204846B2 (ja) * 2007-09-21 2013-06-05 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング エタノールの影響に対して耐性を有する非オピオイド薬のｐＨ依存性制御放出医薬組成物
SI2187876T1 (sl) * 2007-09-21 2012-12-31 Evonik Roehm Gmbh Od pH odvisen opioidni farmacevtski sestavek z nadzorovanim sproščanjem z odpornostjo na vpliv etanola
JP5629581B2 (ja) * 2007-10-12 2014-11-19 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド 食物の摂取から独立した消化器疾患の治療方法
NZ588407A (en) * 2008-03-11 2012-07-27 Takeda Pharmaceutical Orally-disintegrating solid preparation
US8282957B2 (en) 2008-06-26 2012-10-09 Mcneil-Ppc, Inc. Coated particles containing pharmaceutically active agents
KR101535701B1 (ko) * 2008-09-24 2015-07-09 에보니크 룀 게엠베하 에탄올의 영향에 대하여 내성을 갖는 비-오피오이드용 ｐｈ-의존성 조절 방출 제약 조성물
MX2011003047A (es) 2008-09-24 2011-04-14 Evonik Roehm Gmbh Composicion farmaceutica de opioide de liberacion controlada ph dependiente con resistencia contra la influencia de etanol.
CN104984343B (zh) * 2008-09-24 2019-04-02 赢创罗姆有限公司 耐受乙醇影响的非阿片类药物的pH依赖性受控释放的药物组合物
EP2364138A2 (en) * 2008-12-08 2011-09-14 Teva Pharmaceutical Industries Ltd. Palonosetron formulation
BRPI0924427A2 (pt) * 2009-03-18 2016-01-26 Evonik Roehm Gmbh composição farmacêutica de liberação controlada, seu processo de preparação e uso da mesma
WO2010105672A1 (en) * 2009-03-18 2010-09-23 Evonik Röhm Gmbh Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising neutral vinyl polymers and excipients
CN105287434A (zh) * 2009-03-18 2016-02-03 赢创罗姆有限公司 采用含有中性乙烯基聚合物和赋形剂的包衣的具有耐乙醇影响的控释药物组合物
US20100303920A1 (en) * 2009-05-27 2010-12-02 Johan Hjartstam Aqueous Film Coating Composition / 841
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
WO2011047700A1 (en) * 2009-10-22 2011-04-28 Synthon B.V. Pharmaceutical compositions of sevelamer
US9775815B2 (en) * 2011-06-17 2017-10-03 Evonik Roehm Gmbh Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
US9801896B2 (en) 2012-10-17 2017-10-31 Methylation Sciences International Srl Compositions comprising S-adenosylmethionine and a gallic acid ester
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
SI3302444T1 (sl) 2015-06-05 2021-01-29 Evonik Operations Gmbh Farmacevtski ali nutracevtski sestavek z odpornostjo na vpliv etanola
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP6739275B2 (ja) * 2016-08-02 2020-08-12 日本化薬株式会社 ゲフィチニブを有効成分とする医薬組成物
IT201700032367A1 (it) * 2017-03-23 2018-09-23 Lamberti Spa Dispersioni poliuretaniche acquose
MX2020009385A (es) 2018-03-09 2020-10-28 Evonik Operations Gmbh Mezcla de polimeros con resistencia a la influencia del etanol.
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
JP7299595B2 (ja) * 2019-06-07 2023-06-28 日本曹達株式会社 微粒子用の湿式コーティング剤
US20220257517A1 (en) * 2019-06-13 2022-08-18 Evonik Operations Gmbh Powder composition comprising a copolymer mixture and a water-soluble cellulose
CN111700871A (zh) * 2020-06-24 2020-09-25 杭州巴洛特生物科技有限公司 一种美沙拉嗪组合物及其制备方法
CN112237572A (zh) * 2020-10-28 2021-01-19 海南卫康制药(潜山)有限公司 一种富马酸沃诺拉赞片剂及其制备方法
CN114409998A (zh) * 2021-12-24 2022-04-29 浙江普利特新材料有限公司 一种蜂窝状咖啡炭复合隔音降噪聚丙烯材料及其制备方法
US12239623B2 (en) 2023-05-15 2025-03-04 Bonafide Health, Llc Sleep-improving compositions and methods of use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
DE9414066U1 (de) * 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
CZ2002671A3 (cs) * 1999-08-31 2002-06-12 Grünenthal GmbH Léková forma se zpoľděným účinkem obsahující tramadolsacharinát
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
PL367686A1 (en) * 2001-07-16 2005-03-07 Astrazeneca Ab Pharmaceutical formulation comprising a proton pump inhibitor and antacids
KR20040047915A (ko) * 2001-10-15 2004-06-05 룀 게엠베하 운트 콤파니 카게 활성제로서 펩타이드 또는 단백질을 함유하는 생약 형태를제조하기 위한 공중합체의 용도
US20040091538A1 (en) * 2002-10-31 2004-05-13 Crystal Pollock-Dove Dosage form providing ascending release of liquid formulation
EP1589951B1 (en) * 2003-01-03 2017-08-09 Supernus Pharmaceuticals, Inc. Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
MXPA04010956A (es) * 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
WO2005041934A2 (de) * 2003-10-31 2005-05-12 Hexal Ag Pharmazeutische wirkstoffhaltige formulierung mit überzug

Also Published As

Publication number Publication date
MX2007014024A (es) 2008-04-09
BRPI0610206A2 (pt) 2010-06-01
WO2006125483A1 (de) 2006-11-30
EP1890682A1 (de) 2008-02-27
HK1116341A1 (en) 2008-12-19
KR101387835B1 (ko) 2014-04-25
IL187535A0 (en) 2008-03-20
MX363064B (es) 2019-03-06
KR20080009213A (ko) 2008-01-25
CN101137354A (zh) 2008-03-05
CN101137354B (zh) 2014-06-11
BRPI0610206B8 (pt) 2022-07-05
CA2606587A1 (en) 2006-11-30
US20080193522A1 (en) 2008-08-14
CA2606587C (en) 2015-05-26
ES2628962T3 (es) 2017-08-04
EP1890682B1 (de) 2017-05-03
JP5582701B2 (ja) 2014-09-03
SI1890682T1 (sl) 2017-10-30
BRPI0610206B1 (pt) 2020-10-06
JP2008542211A (ja) 2008-11-27
HUE032869T2 (en) 2017-11-28
DE102005024614A1 (de) 2006-11-30

Similar Documents

Publication Publication Date Title
IL187535A0 (en) Use of polymer mixtures for the production of coated pharmaceutical formulations and pharmaceutical formulation with mixed polymeric coating
IL201176A (en) 4-amino-1-h-pyrazolo [3,4- d] pyrimidine-3-ram-phenyl, a pharmaceutical containing them and their use in the preparation of a drug
IL200695A (en) History of Hydro-Oxazolo [2,3-a] Pyrimidine-7-Wen and Pharmaceutical Preparations Containing Them
IL196033A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
EP2147957A4 (en) HYDROPHILIC COATING COMPOSITION AND HYDROPHILIC ELEMENT THEREWITH
IL177283A (en) Pyrazolopyrimidine compounds, their use in the preparation of medicines and pharmaceuticals containing them
IL189187A (en) Polymeric couplings of a252-k and their history, their pharmaceutical preparations and their uses
IL231576A (en) Derivatives of adamantyl-acetamide, the pharmaceutical compositions containing them and their use in the preparation of medicines
IL183583A0 (en) Quinazoline derivatives and pharmaceutical compositions containing the same
IL189782A (en) The history of sulfonylpyrol and its medicinal products and their use
IL210452A (en) Annotations of dimethyl-oxo-dihydro- (pyridine-3-or-4-ram) -phenyl-6-methyl-6-phenyl- [1,3] -oxiazine-2-one
IL199187A (en) Indole history, pharmaceuticals including them and their use in the manufacture of medicines
IL197451A (en) History of Phenylamino and 4-Phenylalkylamino Quinazoline and Pharmaceuticals Containing It
BRPI0814608A2 (pt) Composições de lodo propelente revestido com resina e métodos de produção e uso das mesmas
IL193678A (en) Derivatives of pyrazolyl-theophane, pharmaceuticals containing them and their use in the preparation of drugs to improve cognitive activity
IL195861A0 (en) Thienopyrimidine derivatives and pharmaceutical compositions containing the same
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
ZA200805027B (en) Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers
PL1960482T3 (pl) Stabilna w przechowywaniu kompozycja powłokowa odporna na ścieranie i odporna na zwietrzenie, zapewniająca gładkie powierzchnie nieorganiczne o właściwościach łatwych do czyszczenia
TWI370160B (en) Conductive polymer coating composition, method of preparing coating film using the conductive polymer coating composition, and coating film prepared using the method
IL206125A (en) Derivatives of 7-phenylamino pyrolo [2,1- c] pyrimidine-7-carboxylic acid, esters and their amides, and pharmaceutical preparations containing them
ATE494882T1 (de) Kosmetische formulierung mit glucosylglyceriden und puderrohstoffen
IL202235A (en) Amides and thioamides of 2-phenyl-ethyl-amino-acid, their history and their pharmaceutical preparations
CL2007002619A1 (es) Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
IL201730A (en) History 1h - Benzaimidazole – 2 – Il – Profile – Methyl – Amino – Ethyl – 5 – Aryl – Bicyclo [2.2.2] Oct – 5 – Ann – 2 – All, Pharmaceutical preparations containing them and their use in the preparation of drugs